Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:16:21.784Z.
Calculation as of: 2026-10-06T15:16:21.784Z.
Quote observation: 2026-10-06T15:14:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
EARNINGS YIELD
N/A
Market Cap
$89.11M
Earnings Yield
0.86%
TTM Avg
3.26%
3Y Avg
3.22%
5Y Avg
1.83%
Market Cap
$85.01M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $89.37M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 0.86% | 3.26% | 3.22% | 1.83% |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 3.41% | 2.77% | 2.77% | 8.10% |
| electroCore, Inc. (ECOR)vs › | $92.14M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $92.18M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $85.21M | N/A | 12.67% | 12.67% | 12.67% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.74M | N/A | 39.78% | 39.78% | 39.78% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute